We've already extensively covered why any reasonable appellate court is going to overturn the $500 million judgment against Teva and Baxter over a (now-criminally-charged) doctor's deliberate misuse of propofol. The Wall Street Journal reports that Jay Lefkowitz of Kirkland & Ellis, who successfully argued that federal law requires preemption of state failure-to-warn claims for generic drugs, given the lack of discretion that such generics have, in Pliva v. Mensing, now has another arrow in his quiver for overturning the earlier miscarriage of justice in Nevada. Alas, a lot of damage has already been done thanks to plaintiffs' lawyers putting profits ahead of people.
Did Pliva v. Mensing add another nail in the coffin for the Nevada Teva judgment?
- Mutual Pharmaceutical Co. v. Bartlett
- Suing doctors and drug companies for addiction to pain medication?
- Accutane recusal motion update
- Ninth Circuit refuses to extend Caronia
- More on Higbee recusal motion in Accutane litigation
- More on Caronia
- United States v. Caronia
- Deep pockets files: Greensboro apartment complex murder
- HRT punitive damages before Pennsylvania Supreme Court
- $1M baseball bat verdict overturned in Oklahoma
- Gibson Guitars settles
- Summers v. Tice revisited
- Expert standards in Nevada
- $48 million jackpot justice asbestos award for 86-year-old
- More on Bartlett v. Mutual Pharm.